• home
  • About Us
    • medical centre
    • Our Success Rate
    • Our Commitment
    • Doctors Team
    • Customer Cases
  • Services
    • intrauterine insemination
    • About Follicle Donation
    • About The PGD/PGS
    • About Assisted Reproduction Services
    • About In Vitro Fertilisation
    • About Gender Selection
    • About Testicular Sperm Extraction
    • About Fertility Diagnostic Testing
    • About Fertility Preservation
  • Services Objects
    • Women of advanced age
    • Same-sex families
    • immunological infertility
    • genetic disorder
    • chromosomal abnormality
    • male infertility
    • tubal infertility
    • Polycystic Ovary Syndrome (PCOS): A Comprehensive Analysis and Guidelines for Fertility Management
    • nongamous person
    • HIV carrier
  • NEWS
    • Company News
    • Surrogacy Industry News
    • Surrogacy techniques
  • Package cost
    • For infertile families
    • For unmarried men
    • For unmarried women
  • Contact Us
Home » Surrogacy News » Surrogacy techniques » Farewell to the era of “blind selection”! Six Non-Invasive Techniques to Accurately Screen “Champion Embryos” for IVF

Farewell to the era of “blind selection”! Six Non-Invasive Techniques to Accurately Screen “Champion Embryos” for IVF

Date: 06/30/2025

In the field of assisted reproduction, a quiet revolution is revolutionizing the rules of IVF. Traditional embryo screening relies on visual observation by embryologists and invasive biopsies, which are not only subjective, but can also damage precious embryos. Nowadays, non-invasive embryo screening technology can accurately assess the developmental potential of embryos without touching them by analyzing trace biomarkers in the embryo culture fluid, pushing the IVF success rate to a new high.

IVF

I. AI-enabled “Time Detective”: Embryo Development Tracking System

Embryo evaluation has evolved from static “face painting” to dynamic “life documentary”.

Time-lapse imaging + AI algorithm: The time-lapse imaging system records the embryo’s developmental trajectory every 10 minutes, while the AI algorithm analyzes 35 morphodynamic parameters such as the synchronization of cleavage and the speed of blastocyst expansion. Data from the University of Cambridge Reproduction Center showed that AI-assisted screening increased the identification rate of high-quality embryos to 89%, and the accuracy of live birth prediction reached 85%.

3D reconstruction breakthrough: The Stanford team developed a virtual 3D model of the embryo that can visualize the internal structure of the blastocyst, with an aneuploidy detection accuracy of 83%, effectively avoiding the risk of miscarriage caused by chromosomal abnormalities by more than 60%.

Clinical effectiveness controversy: Although widely promoted in European reproduction centers, two multi-center RCTs showed that the difference in pregnancy rate did not reach a significant level compared to traditional morphology, and the investment in equipment was as high as $200,000, which restricts the popularization of the clinic.

II.The non-invasive revolution of DNA: culture fluid free chromosome screening (NICS)

When traditional biopsy faces the risk of chimerism misdiagnosis and embryo damage, NICS technology is becoming the new gold standard.

Technological breakthrough: By capturing 5-10 pg/μL of free DNA in embryo culture fluid, 23 pairs of chromosomes are analyzed for integrality within 8 hours by whole genome amplification (WGA) and high-throughput sequencing. Johns Hopkins School of Medicine validated the sensitivity to be 99.2%, comparable to traditional PGT-A.

Eye-catching clinical data: A study of 273 patients with recurrent implantation failures showed a significantly higher clinical pregnancy rate in the NICS group (46.9%) than in the control group (28.7%), a decrease in miscarriage rate from 42.6% to 17.9%, and a near-doubling of the live-birth rate (38.9% vs. 20.6%).1 

Cost-benefit advantage: Avoidance of trophectoderm biopsies reduces the cost of the assay by 40% and improves the embryo utilization rate by 20%, especially for balanced translocations. Cost-effectiveness: avoidance of trophoblast biopsy reduces the cost of testing by 40% and improves embryo utilization by 20%, which is particularly suitable for balanced translocation carriers (58% pregnancy rate).

III.Gene activity code: “molecular radar” for miRNAs and piRNAs.

Non-coding RNAs secreted by the embryo are emerging as ultra-early signals to assess developmental potential.

miRNA regulatory network: The Košice Fertility Center found a 230% surge in hsa-miR-16-5p expression in cultures of embryos that failed to implant. This molecule weakens the embryo-endometrial dialog by inhibiting the VEGFA pathway.

Dual-marker early warning system: The Karolinska Institutet School of Medicine in Sweden targeted the combination of hsa-miR-199a-5p and hsa-miR-432-5p, which predicted pregnancy with an area under the ROC curve (AUC) of 0.87, a 35% enhancement compared to a single morphology assessment.6 

Rapid testing solution: qRT-PCR technology can complete the analysis 2 hours before implantation, but it requires specialized laboratory However, specialized laboratory support is required, and the cost of single-sample testing is approximately $12.

IV.Protein Fingerprinting: Mass Spectrometry Decoding the Embryonic Secretome

The protein profile secreted by the embryo is like a dynamic life code, and a team from the University of Heidelberg, Germany, used MALDI-TOF MS to unravel its mysteries.

The 12 characteristic peaks of aneuploid embryos: By comparing embryo cultures verified by PGT-A, a combination of high sHLA-G expression and low sCD146 expression was found to have a positive predictive value of 91% for predicting a sustained pregnancy.

Ultra-rapid clinical pathway: only 1 μL of culture fluid is required and results are output in 20 minutes to support day-of-implantation decision-making. However, culture medium differences can lead to 30% signal drift and standardization is urgently needed.

V. Metabolic Trajectory Tracking: Capturing the Energy Code by Raman Spectroscopy

Embryonic metabolic shifts conceal developmental mysteries, and energy metabolism transition points become key assessment windows.

Metabolic Marker Targeting: The UCLA team found that tyrosine and tryptophan levels in the culture fluid of successfully pregnant embryos decreased by 15% and serine increased by 8% through Raman spectroscopy, suggesting increased glycolytic activity. The machine learning model achieved a pregnancy prediction accuracy of 71.5%.

Technological standardization dilemmas: RCT studies with near-infrared spectroscopy (NIR) have not been shown to be superior to morphological assessment, and nuclear magnetic resonance (NMR) equipment is expensive (>$500,000) and significantly affected by culture media batch.

VI. Extracellular vesicles: nanoscale life messengers

Extracellular vesicles (EVs), 100-300 nm in diameter, are becoming a “microscopic intelligence station” for assessing embryo quality.

Characterization of EVs in successful pregnancies: Massachusetts General Hospital (MGH) showed that EVs secreted by live-born embryos have: 

✅ Particle concentration >2.8×10⁹/mL 

✅ Mean particle size >220 nm 

✅ Low expression of specific miR-92a-3p 

Significantly different from that of non-live-born embryos (P<0.01) 

Multi-technology protocol: Nanoparticle Tracking Assay (NTA) combined with flow cytometry. NTA combined with flow cytometry can detect the nucleic acid content of EVs in less than 30 minutes at a cost of less than $50, but more RCTs are needed for validation.

Clinical Pain Point: How Non-Invasive Technologies Are Reshaping the IVF Landscape

Patient Benefits

Repeated implantation failures: pregnancy rate from 28.7% to 46.9%, miscarriage rate from 42.6% to 17.9% 

Elderly women (>38 years old): live birth rate increased to 38.9%, avoiding the risk of preterm labor associated with multiple pregnancies 

Relief of financial pressure: NICS reduces the cost of a single cycle by $1200, and saves embryo freezing fees by $500/year

Clinical Decision Optimization

New solutions for complex cases: diagnostic accuracy of chimeric embryos increased to 95%, 65% screening rate of normal embryos in balanced translocations 

Same-day transfer realized: proteomic and metabolomic analysis supports evaluation within 2 hours, 40% reduction in cycle time

Industry Transformation

Equipment market explosion: time-delay system annual growth rate of 37%, AI embryo rating software market value exceeded $800 million 

Expanded health insurance coverage: Shanghai and Guangzhou will include NICS in assisted reproduction health insurance payment from 2025, and out-of-pocket expenses will be reduced to 30%.

Far-reaching Impact: Redefining the Beginning of Life

When non-invasive techniques made single embryo transfer (SET) mainstream, the rate of multiple pregnancies dropped from 30% to 8%, and the incidence of preterm birth fell by 45%. This not only reduced the physical and financial burden on patients (average savings of $23,000 in complication treatment), but also reshaped the ethical framework of assisted reproduction from the ground up.

With the introduction of CRISPR gene editing and mitochondrial replacement into the clinic, what was once a “fertility dead zone” is becoming a “hope zone”. The cornerstone of all of this begins with our gentlest touch on the embryo – letting go and allowing it to freely display the codes of life and wait for the flowers to bloom.

Previous post: Sperm quality warning men's health

相关推荐

  • Sperm quality warning men’s health
  • Strategies for Improving IVF Embryo Quality
  • Male stress actually rewrites offspring genes? Nature reveals transgenerational genetic code of sperm RNAs
  • Did iron deficiency during pregnancy actually cause fetal sex reversal? Nature study reveals developmental code
  • Metformin is the hidden key to IVF success

Search within the site

Surrogacy News

  • Company News
  • Surrogacy Industry News
  • Surrogacy techniques
  • home
  • About Us
    • medical centre
    • Our Success Rate
    • Our Commitment
    • Doctors Team
    • Customer Cases
  • Services
    • intrauterine insemination
    • About Follicle Donation
    • About The PGD/PGS
    • About Assisted Reproduction Services
    • About In Vitro Fertilisation
    • About Gender Selection
    • About Testicular Sperm Extraction
    • About Fertility Diagnostic Testing
    • About Fertility Preservation
  • Services Objects
    • Women of advanced age
    • Same-sex families
    • immunological infertility
    • genetic disorder
    • chromosomal abnormality
    • male infertility
    • tubal infertility
    • Polycystic Ovary Syndrome (PCOS): A Comprehensive Analysis and Guidelines for Fertility Management
    • nongamous person
    • HIV carrier
  • NEWS
    • Company News
    • Surrogacy Industry News
    • Surrogacy techniques
  • Package cost
    • For infertile families
    • For unmarried men
    • For unmarried women
  • Contact Us

Hot Tags.

ivf

TATECARE International Reproductive Group was established in 2011 to reshape the lives of families around the world.

Latest Articles

  • Sperm quality warning men’s health
  • 35+ Women’s Guide to Scientific Preparation for Pregnancy: Medical Strategies and Health Management for Fertility at Advanced Ages
  • Strategies for Improving IVF Embryo Quality

SurrogacyNews

  • Scientific Selection Guide for Natural Fertilization vs IVF
  • Deadly Warning of Fetal Motion Disappearing at 38 Weeks|International Center for Perinatal Medicine
  • A Complete Guide to Monitoring Natural Cycles and Ovulation Promotion Programs

NEWS

  • Company News
  • Surrogacy Industry News
  • Surrogacy techniques

Georgia Surrogacy Services,Legal IVF Hospital,Global Fertility Agency

Go to top
home home
 customers customers
Service Service
About About